Abstract

Basics of Compounding for Hazardous Drugs, Part 1: An Introduction

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2006 - Dermatology

Page(s): 377-379

Download in electronic PDF format for $75

Abstract

National Institute of Occupational Safety and Health Publication No. 2004–165, Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings, was published in 2004 to increase the awareness of healthcare workers and other professionals about the health risks of working with hazardous drugs and to provide measures for protecting their health. The health risks to employees who prepare or administer hazardous drugs in the workplace is influenced by many factors, and each compounding facility is responsible for developing its own list of hazardous drugs and for creating standard operating procedures to reduce risks as much as possible for employees. To provide employees with the greatest protection, employers should (1) implement necessary administrative and engineering controls, and (2) assure that the workers use sound procedures and proper protective equipment for handling hazardous drugs.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2006 Pg. 377-379	Basics of Compounding for Hazardous Drugs, Part 1: An Introduction Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 446-448	Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 30-36	Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Author(s): Dillon L R
Mar/Apr 2007 Pg. 149-151	Basics of Compounding for Hazardous Drugs, Part 4: Developing the Hazardous Drugs List and Containment Workstations Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 182-186	How to Develop and Maintain a Hazardous Drug List Author(s): Dillon L Rad
Sep/Oct 2022 Pg. 358-362	Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration Author(s): Lopez C Vidal, Rios GL Quito
Mar/Apr 2004 Pg. 126-129	Basics of Compounding for the Treatment of Warts Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 261-263	Compounding Using Hazardous Drugs Author(s): Lau Kellie
Sep/Oct 2017 Pg. 356	PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 56-62	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs Author(s): Allen Loyd V Jr, Okeke Claudia C
Sep/Oct 2014 Pg. 358-364	Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy Author(s): Palma Elisabetta, Bufarini Celestino
Jul/Aug 2002 Pg. 267-270	Facilities and Procedures for Compounding Hazardous Drugs Author(s): Rahe Hank
Jul/Aug 2009 Pg. 300-310	Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting Author(s): McElhiney Linda F
Jan/Feb 2007 Pg. 50-51	Basics of Compounding for Hazardous Drugs, Part 3: Safe Handling and Personal Protection Author(s): Allen Loyd V Jr
Nov/Dec 2020 Pg. 451-458	Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety Author(s): Allen W Chris, Greeson Nicole MH, Mixon William
Sep/Oct 2018 Pg. 387-398	Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Author(s): Ashe Krystina, Baskett Dustin
Nov/Dec 2021 Pg. 515-522	Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding Author(s): Soefje Scott, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Jan/Feb 2022 Pg. 72-79	Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint) Author(s): Soefje Scott, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Nov/Dec 2011 Pg. 526-527	PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Author(s): Williams LaVonn A
Sep/Oct 2015 Pg. 377-380	The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists Author(s): Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake